company background image
524400 logo

Ishita Drugs and Industries BSE:524400 Stock Report

Last Price

₹89.79

Market Cap

₹268.5m

7D

4.4%

1Y

17.6%

Updated

30 Dec, 2024

Data

Company Financials

Ishita Drugs and Industries Limited

BSE:524400 Stock Report

Market Cap: ₹268.5m

524400 Stock Overview

Manufactures and sells active pharma ingredients (APIs), fine chemicals, drug intermediates, and excipients in India and internationally. More details

524400 fundamental analysis
Snowflake Score
Valuation3/6
Future Growth0/6
Past Performance4/6
Financial Health5/6
Dividends0/6

Rewards

Trading at 89.7% below our estimate of its fair value

Earnings have grown 5.1% per year over the past 5 years

Risk Analysis

Does not have a meaningful market cap (₹268M)

Does not have meaningful revenue (₹140M)


My Notes

Capture your thoughts, links and company narrative

Ishita Drugs and Industries Limited Competitors

Bacil Pharma

BSE:524516

₹326.5m

Colinz Laboratories

BSE:531210

₹176.6m

Evoq Remedies

BSE:543500

₹194.2m

Hamps Bio

BSE:544312

₹379.1m

Price History & Performance

Summary of share price highs, lows and changes for Ishita Drugs and Industries
Historical stock prices
Current Share Price₹89.79
52 Week High₹104.75
52 Week Low₹56.00
Beta0.28
1 Month Change2.66%
3 Month Change12.63%
1 Year Change17.60%
3 Year Change94.14%
5 Year Change554.45%
Change since IPO945.29%

Recent News & Updates

Recent updates

Shareholder Returns

524400IN PharmaceuticalsIN Market
7D4.4%1.7%0.2%
1Y17.6%39.1%17.2%

Return vs Industry: 524400 underperformed the Indian Pharmaceuticals industry which returned 39.1% over the past year.

Return vs Market: 524400 matched the Indian Market which returned 17.2% over the past year.

Price Volatility

Is 524400's price volatile compared to industry and market?
524400 volatility
524400 Average Weekly Movement6.9%
Pharmaceuticals Industry Average Movement6.0%
Market Average Movement6.2%
10% most volatile stocks in IN Market9.1%
10% least volatile stocks in IN Market4.1%

Stable Share Price: 524400 has not had significant price volatility in the past 3 months compared to the Indian market.

Volatility Over Time: 524400's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
199217Jagdishprasad Agrawalwww.ishitadrugs.com

Ishita Drugs and Industries Limited manufactures and sells active pharma ingredients (APIs), fine chemicals, drug intermediates, and excipients in India and internationally. The company offers APIs, such as sulfa drugs/sulfonamides, vitamins, fluoro quinolones, antibiotics, anthelmintics, iodides and citrates, food additives/excipients, and others. It provides contract manufacturing services for various drug intermediates, fine chemicals, or specialty chemicals.

Ishita Drugs and Industries Limited Fundamentals Summary

How do Ishita Drugs and Industries's earnings and revenue compare to its market cap?
524400 fundamental statistics
Market cap₹268.50m
Earnings (TTM)₹7.43m
Revenue (TTM)₹140.08m

36.1x

P/E Ratio

1.9x

P/S Ratio

Is 524400 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
524400 income statement (TTM)
Revenue₹140.08m
Cost of Revenue₹118.36m
Gross Profit₹21.72m
Other Expenses₹14.29m
Earnings₹7.43m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)2.49
Gross Margin15.51%
Net Profit Margin5.31%
Debt/Equity Ratio20.6%

How did 524400 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/30 00:34
End of Day Share Price 2024/12/30 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Ishita Drugs and Industries Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution